Oncopeptides AB Financial Flexibility Index
Oncopeptides AB financial flexibility index. Oncopeptides AB (ONCO) has a Financial Flexibility Index of -1.12x as of December 2025. Free cash flow of Skr-216.49 Million (operating CF Skr-216.49 Million minus capex Skr0.00) represents -1% of total liabilities (Skr193.73 Million). See Oncopeptides AB (ONCO) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Oncopeptides AB (2014–2025)
Financial flexibility index of Oncopeptides AB from 2014 to 2025. Historical Financial Flexibility Index trend for Oncopeptides AB across 12 annual periods. Explore ONCO cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Oncopeptides AB Financial Flexibility Index by Year (2014–2025)
Oncopeptides AB financial flexibility index by year from 2014 to 2025. Year-by-year free cash flow to debt coverage for Oncopeptides AB. For the full cash flow conversion analysis, see Oncopeptides AB operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.15x | Skr-222.88 Million | Skr-222.88 Million | Skr193.73 Million | ▲ +16.0% |
| 2024 | -1.37x | Skr-260.21 Million | Skr-260.57 Million | Skr189.91 Million | ▲ +10.9% |
| 2023 | -1.54x | Skr-279.38 Million | Skr-279.49 Million | Skr181.60 Million | ▲ +66.5% |
| 2022 | -4.59x | Skr-418.00 Million | Skr-420.51 Million | Skr91.03 Million | ▲ +30.8% |
| 2021 | -6.63x | Skr-1.52 Billion | Skr-1.52 Billion | Skr228.51 Million | ▼ -91.8% |
| 2020 | -3.46x | Skr-1.28 Billion | Skr-1.30 Billion | Skr369.86 Million | ▲ +1.2% |
| 2019 | -3.50x | Skr-687.94 Million | Skr-690.57 Million | Skr196.47 Million | ▼ -35.2% |
| 2018 | -2.59x | Skr-333.36 Million | Skr-333.73 Million | Skr128.70 Million | ▲ +40.7% |
| 2017 | -4.37x | Skr-270.02 Million | Skr-271.50 Million | Skr61.82 Million | ▼ -24.1% |
| 2016 | -3.52x | Skr-103.15 Million | Skr-104.26 Million | Skr29.30 Million | ▲ +52.3% |
| 2015 | -7.38x | Skr-51.69 Million | Skr-52.81 Million | Skr7.00 Million | ▼ -34.3% |
| 2014 | -5.50x | Skr-30.32 Million | Skr-31.44 Million | Skr5.52 Million | — |